Signaling control of the constitutive androstane receptor (CAR)

Area of Science:

• Molecular Biology
• Pharmacology
• Biochemistry

Background:

• The constitutive androstane receptor (CAR, NR1I3) is a key regulator of drug metabolism, energy balance, and cancer.
• CAR activation occurs via direct ligand binding or ligand-independent mechanisms, both involving nuclear translocation.
• While direct activation is well-understood, indirect CAR activation mechanisms, particularly nuclear translocation, require further elucidation.

Purpose of the Study:

• To review recent advancements in understanding the signaling pathways that regulate CAR nuclear accumulation and activation.
• To compare and contrast the mechanisms of direct versus indirect activation of human CAR.
• To provide a comprehensive overview of CAR's role in cellular processes.

Main Methods:

• Literature review of recent scientific publications on CAR signaling.
• Analysis of studies investigating CAR's cytoplasmic protein complex formation.
• Synthesis of data on signaling pathway involvement in CAR nuclear translocation.

Main Results:

• CAR forms a cytoplasmic protein complex influenced by various signaling pathways prior to activation.
• Ligand-independent CAR activation relies on mechanisms that facilitate nuclear translocation.
• Recent progress has shed light on the signaling regulation governing CAR's nuclear entry and subsequent activation.

Conclusions:

• Understanding CAR's indirect activation is crucial for comprehending its multifaceted roles.
• Further research into signaling-dependent CAR nuclear translocation is warranted.
• This review highlights key similarities and differences between direct and indirect CAR activation pathways.